Results from the Childhood Cancer Survivor Study (CCSS) show that current advances in treatment and follow-up have led to improved survival of childhood cancers, including lymphoma, especially by reducing deaths due to lingering effects of cancer treatment. The study, performed at St. Jude Children’s Research Hospital, was published in the online edition of the New England Journal of Medicine.
The extensive study looked at 34,033 children and adolescents diagnosed with cancer between 1970 and 1999. All participants were considered long-term survivors, living at least five years following diagnosis.
The results show that the death rate — particularly the 15-year death rate — among young cancer patients has decreased significantly since 1970, partly because of a reduction in treatment-related health complications. Data from 1970-74 and 1990-94 showed a decline from 12.6 percent to 6 percent among patients. Deaths due to secondary complications of treatment also decreased, from 3.5 percent to 2.1, percent during those time periods.
Read the full article at lymphomanewstoday.com